A good adherence to ELN 09 recommendations in chronic myeloid leukemia (CML) treatment with imatinib, is associated with better outcomes in patients treated outside clinical trials
Fecha de publicación
2012Título de revista
Blood
Tipo de contenido
Publicación de congreso